Evidence map›Paper›PMID 37528411›Full record

ArticleGenome biology2023

Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes.

Francisco Avila Cobos, Mohammad Javad Najaf Panah, Jessica Epps, Xiaochen Long, Tsz-Kwong Man, Hua-Sheng Chiu, Elad Chomsky, Evgeny Kiner, Michael J Krueger, Diego di Bernardo and 8 more

Abstract read
In one paragraph

Article in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. [A multi-level study of androgen deprivation therapy on the immune microenvironment in prostate cancer].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  2. Article
  3. TheBMJ open respiratory research · 2026
    Observational
  4. Article
  5. Integration of Bulk and Single-Cell RNA Sequencing Analyses in Biomedicine.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francisco Avila Cobos *Department of Biomolecular Medicine, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium.
Mohammad Javad Najaf Panah *Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Jessica EppsDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Xiaochen LongDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Tsz-Kwong ManDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Hua-Sheng ChiuDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Elad Chomsky, ImmunAi, New York, NY, USA.
Evgeny Kiner, ImmunAi, New York, NY, USA.
Michael J KruegerDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Diego di BernardoDepartment Chemical, Materials and Industrial Engineering, Telethon Institute of Genetics and Medicine, University of Naples "Federico II", Via Campi Flegrei 34, 80078, Naples, Pozzuoli, Italy.
Luis Voloch, ImmunAi, New York, NY, USA.
Jan MolenaarPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Sander R van HooffPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Frank WestermannGerman Cancer Research Center, DKFZ, Heidelberg, Germany.
Selina JanskyGerman Cancer Research Center, DKFZ, Heidelberg, Germany.
Michele L RedellDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA.
Pieter MestdaghDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium. pieter.mestdagh@ugent.be.
Pavel SumazinDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, USA. sumazin@bcm.edu.ORCID 0000-0002-1215-4977

Funding

VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
High Throughput Genomic Sequencer at BCM Core FacilityS10OD023469 · OD · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2017 to 2017
$600k
Acquisition of the Fluidigm system to accelerate functional genomics researchS10OD018033 · OD · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2014 to 2014
$396k
Diagnostic biomarkers for hepatoblastomas with hepatocellular carcinoma featuresR21CA223140 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SUMAZIN, PAVEL · 2019 to 2020
$383k
Acquisition of 10X Genomics Chromium Instrument to Accelerate Genomic and Single Cell Transcriptomic ResearchS10OD025240 · OD · BAYLOR COLLEGE OF MEDICINE · PI DODDAPANENI, HARSHA VARDHAN · 2018 to 2018
$125k
NCI NIH HHS R21 CA223140NEI NIH HHS P30 EY002520NIH HHS S10 OD018033NIH HHS S10 OD023469NIH HHS S10 OD025240
6 · The paper itself

Abstract

backgroundRNA profiling technologies at single-cell resolutions, including single-cell and single-nuclei RNA sequencing (scRNA-seq and snRNA-seq, scnRNA-seq for short), can help characterize the composition of tissues and reveal cells that influence key functions in both healthy and disease tissues. However, the use of these technologies is operationally challenging because of high costs and stringent sample-collection requirements. Computational deconvolution methods that infer the composition of bulk-profiled samples using scnRNA-seq-characterized cell types can broaden scnRNA-seq applications, but their effectiveness remains controversial.

resultsWe produced the first systematic evaluation of deconvolution methods on datasets with either known or scnRNA-seq-estimated compositions. Our analyses revealed biases that are common to scnRNA-seq 10X Genomics assays and illustrated the importance of accurate and properly controlled data preprocessing and method selection and optimization. Moreover, our results suggested that concurrent RNA-seq and scnRNA-seq profiles can help improve the accuracy of both scnRNA-seq preprocessing and the deconvolution methods that employ them. Indeed, our proposed method, Single-cell RNA Quantity Informed Deconvolution (SQUID), which combines RNA-seq transformation and dampened weighted least-squares deconvolution approaches, consistently outperformed other methods in predicting the composition of cell mixtures and tissue samples.

conclusionsWe showed that analysis of concurrent RNA-seq and scnRNA-seq profiles with SQUID can produce accurate cell-type abundance estimates and that this accuracy improvement was necessary for identifying outcomes-predictive cancer cell subclones in pediatric acute myeloid leukemia and neuroblastoma datasets. These results suggest that deconvolution accuracy improvements are vital to enabling its applications in the life sciences.

Indexed as

Gene Expression ProfilingTranscriptomeChildHumansRNA-SeqRNA, Small InterferingSequence Analysis, RNASingle-Cell AnalysisRNA, Small Interfering

Identifiers

PMID37528411
PMCPMC10394903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.